Last edition
News about "AstraZeneca partners with Algen Biopharmaceuticals"
AstraZeneca Partners with Algen Biopharmaceuticals in USD 555 Million Gene Therapy Deal
AstraZeneca has entered into a collaboration and licence agreement valued at up to USD 555 million with United States–based biotechnology company Algen Biopharmaceuticals to develop gene therapies targeting rare diseases.
AstraZeneca Partners With Algen Biopharmaceuticals | 07/10/2025 | By Darshana | 203
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members